Coty Executives Face Securities Class Action Lawsuit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 07 2026
0mins
Should l Buy COTY?
Source: PRnewswire
- Significant Stock Decline: Coty's shares plummeted from $3.43 to $2.66, a loss of $0.77 (22%), primarily due to the company's withdrawal of its $1 billion adjusted EBITDA target and admission of widespread operational failures, severely undermining investor confidence.
- Executive Liability Allegations: CEO Sue Nabi and CFO Laurent Mercier are named as individual defendants, facing accusations of being controlling persons responsible for the company's operational failures, which raises serious concerns about corporate governance and accountability.
- Legal Framework Basis: Under Section 20(a) of the Securities Exchange Act of 1934, controlling individuals may be held liable for securities law violations, with the lawsuit asserting that both executives failed to ensure the accuracy of disclosures during their tenure, potentially leading to severe repercussions.
- Internal Data Misrepresentation: The lawsuit claims that both executives, while certifying SEC filings, were aware of significant discrepancies between internal data and the positive growth narrative presented to investors, indicating possible willful or reckless disregard for shareholder interests.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COTY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COTY
Wall Street analysts forecast COTY stock price to rise
12 Analyst Rating
1 Buy
9 Hold
2 Sell
Hold
Current: 2.130
Low
2.50
Averages
4.30
High
10.00
Current: 2.130
Low
2.50
Averages
4.30
High
10.00
About COTY
Coty Inc. is a beauty company with a portfolio of brands across fragrance, color cosmetics, and skin and body care. The Company has a diverse portfolio of brands, which includes both owned and licensed. Its brand portfolio is classified into two segments: Consumer beauty and Prestige. The consumer beauty brands include Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Mexx, LeGer by Lena Gercke, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, and Vera Wang. Its prestige brands include Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, and Tiffany & Co. Its mass beauty brands are primarily sold through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. It markets, sells and distributes its products in over 120 countries and territories.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Coty Faces Class Action Lawsuit Over Securities Violations
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Coty Inc., aiming to recover damages for investors who purchased Coty securities between November 5, 2025, and February 4, 2026, highlighting significant investor concerns regarding the company's financial transparency.
- Allegations of False Statements: The complaint alleges that Coty's executives made materially false and misleading statements about the company's growth and profitability prospects during the class period, failing to disclose underperformance in its Consumer Beauty segment and slowing market growth, which could lead to misjudgments about the company's future.
- Profit Pressure Factors: The lawsuit points out that Coty's margins are being pressured by increased marketing expenditures, and the deceleration in growth within its Prestige fragrance segment may impact the company's long-term profitability and market confidence.
- Investor Rights Protection: Bronstein, Gewirtz & Grossman, LLC offers risk-free legal services, promising to charge fees only upon successful recovery, aiming to protect investor rights and restore capital, which underscores their commitment to market integrity.
See More
Consumer Staples Struggle, Coty Faces Challenges
- Consumer Stock Performance: Over the past six months, consumer staples stocks have declined by 2.3%, contrasting with the S&P 500's 10% rise, indicating a diminishing defensive investment characteristic in volatile markets.
- Coty's Financial Struggles: With a market cap of $2.01 billion, Coty has shown no organic revenue growth over the past two years, and demand is expected to decline in the next 12 months, leading to a 29.3% annual drop in earnings per share, highlighting severe profitability issues.
- Colgate-Palmolive's Strength: Colgate-Palmolive, valued at $69.97 billion, boasts a revenue base of $20.8 billion and a gross margin of 60.4%, demonstrating strong customer loyalty and market influence, making it a stock worth watching.
- Philip Morris's Robust Performance: With a market cap of $291.3 billion, Philip Morris showcases a highly efficient business model with a gross margin of 66.5% and an operating margin of 36.5%, indicating strong cash flow capabilities that attract investor interest.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit representing investors who purchased its stock between November 5, 2025, and February 4, 2026, following serious operational issues and the abrupt departure of CEO Sue Y. Nabi, which caused the stock price to drop over 8% on the announcement day.
- Deteriorating Financial Performance: In its Q2 2026 earnings report, Coty revealed that its Consumer Beauty segment's operating income plummeted over 70% year-over-year, while Prestige fragrance income fell over 18%, indicating significant challenges in market competition and failure to meet its $1 billion EBITDA target.
- Management Changes: The unexpected announcement of CEO Nabi's departure on December 12, 2025, without explanation, has raised investor concerns regarding corporate governance and future strategy, especially as the company failed to improve sales trends as promised.
- Investor Rights Protection: Hagens Berman is investigating whether Coty intentionally misled investors and is urging those who suffered significant losses to submit their information, while also encouraging witnesses to assist in the ongoing investigation.
See More
Coty Faces Class Action Lawsuit Amid Disappointing Earnings and Stock Plunge
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Coty, alleging securities fraud by the company and its executives, with investors needing to apply as Lead Plaintiff by May 22, 2026, highlighting serious governance concerns.
- Disappointing Earnings: In its Q2 fiscal 2026 report, Coty revealed worsening performance in its Consumer Beauty segment, leading to the withdrawal of its EBITDA guidance and a downward revision of its near-term outlook, reflecting macroeconomic pressures and uncertain consumer demand.
- Stock Price Plunge: Following the disappointing earnings report, Coty's stock price fell by $0.77, or 22.45%, over two trading sessions, closing at $2.66, indicating a pessimistic market outlook on the company's future.
- Management Changes Impact: The recent transition of Coty's CEO, coupled with poor performance, suggests a lack of operational discipline, which may further undermine investor confidence and market performance.
See More
Multiple Companies Face Class Action Lawsuits
- Atara Biotherapeutics Lawsuit: Atara faces a class action from May 20, 2024, to January 9, 2026, alleging that manufacturing issues and clinical trial risks overstated its FDA approval prospects, potentially leading to significant negative impacts on its financial condition.
- Coty's Underperformance: Coty Inc. is involved in a class action from November 5, 2025, to February 4, 2026, claiming that its Consumer Beauty segment underperformed and increased marketing investments compressed margins, rendering the company's positive statements materially misleading.
- Super Micro Computer Compliance Issues: Super Micro Computer faces a class action from February 2, 2024, to March 19, 2026, due to server sales to Chinese companies violating U.S. export control laws, indicating material weaknesses in compliance controls that jeopardize business prospects.
- ImmunityBio's Overstated Capabilities: ImmunityBio is part of a class action from January 19, 2026, to March 24, 2026, alleging that executive claims about Anktiva's capabilities were materially misleading, which could undermine investor confidence in the company's operations.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit for allegedly misleading investors during the period from November 5, 2025, to February 4, 2026, following serious operational issues highlighted in its Q2 2026 earnings report and the abrupt departure of CEO Nabi, which has heightened market anxiety.
- Stock Price Impact: Following the earnings report on February 5, 2026, Coty's stock price fell over 8% that day, reflecting investor concerns about the company's future profitability, particularly after its Consumer Beauty segment reported a staggering 70% year-over-year drop in operating income.
- Market Reaction: Hagens Berman is investigating whether Coty intentionally misled investors, especially given its earlier assurances of improving sales trends for FY 2026, while the reality showed underperformance in the Consumer Beauty market and compressed margins due to increased marketing investments.
- Management Changes: The sudden departure of CEO Nabi has raised questions about the stability of Coty's management, with analysts suggesting this may be linked to the company's failure to accurately disclose its business trends, further undermining investor confidence in Coty's future prospects.
See More
Coty Faces Class Action Lawsuit Over Securities Violations
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Coty Inc., aiming to recover damages for investors who purchased Coty securities between November 5, 2025, and February 4, 2026, highlighting significant investor concerns regarding the company's financial transparency.
- Allegations of False Statements: The complaint alleges that Coty's executives made materially false and misleading statements about the company's growth and profitability prospects during the class period, failing to disclose underperformance in its Consumer Beauty segment and slowing market growth, which could lead to misjudgments about the company's future.
- Profit Pressure Factors: The lawsuit points out that Coty's margins are being pressured by increased marketing expenditures, and the deceleration in growth within its Prestige fragrance segment may impact the company's long-term profitability and market confidence.
- Investor Rights Protection: Bronstein, Gewirtz & Grossman, LLC offers risk-free legal services, promising to charge fees only upon successful recovery, aiming to protect investor rights and restore capital, which underscores their commitment to market integrity.
See More
Consumer Staples Struggle, Coty Faces Challenges
- Consumer Stock Performance: Over the past six months, consumer staples stocks have declined by 2.3%, contrasting with the S&P 500's 10% rise, indicating a diminishing defensive investment characteristic in volatile markets.
- Coty's Financial Struggles: With a market cap of $2.01 billion, Coty has shown no organic revenue growth over the past two years, and demand is expected to decline in the next 12 months, leading to a 29.3% annual drop in earnings per share, highlighting severe profitability issues.
- Colgate-Palmolive's Strength: Colgate-Palmolive, valued at $69.97 billion, boasts a revenue base of $20.8 billion and a gross margin of 60.4%, demonstrating strong customer loyalty and market influence, making it a stock worth watching.
- Philip Morris's Robust Performance: With a market cap of $291.3 billion, Philip Morris showcases a highly efficient business model with a gross margin of 66.5% and an operating margin of 36.5%, indicating strong cash flow capabilities that attract investor interest.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit representing investors who purchased its stock between November 5, 2025, and February 4, 2026, following serious operational issues and the abrupt departure of CEO Sue Y. Nabi, which caused the stock price to drop over 8% on the announcement day.
- Deteriorating Financial Performance: In its Q2 2026 earnings report, Coty revealed that its Consumer Beauty segment's operating income plummeted over 70% year-over-year, while Prestige fragrance income fell over 18%, indicating significant challenges in market competition and failure to meet its $1 billion EBITDA target.
- Management Changes: The unexpected announcement of CEO Nabi's departure on December 12, 2025, without explanation, has raised investor concerns regarding corporate governance and future strategy, especially as the company failed to improve sales trends as promised.
- Investor Rights Protection: Hagens Berman is investigating whether Coty intentionally misled investors and is urging those who suffered significant losses to submit their information, while also encouraging witnesses to assist in the ongoing investigation.
See More
Coty Faces Class Action Lawsuit Amid Disappointing Earnings and Stock Plunge
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Coty, alleging securities fraud by the company and its executives, with investors needing to apply as Lead Plaintiff by May 22, 2026, highlighting serious governance concerns.
- Disappointing Earnings: In its Q2 fiscal 2026 report, Coty revealed worsening performance in its Consumer Beauty segment, leading to the withdrawal of its EBITDA guidance and a downward revision of its near-term outlook, reflecting macroeconomic pressures and uncertain consumer demand.
- Stock Price Plunge: Following the disappointing earnings report, Coty's stock price fell by $0.77, or 22.45%, over two trading sessions, closing at $2.66, indicating a pessimistic market outlook on the company's future.
- Management Changes Impact: The recent transition of Coty's CEO, coupled with poor performance, suggests a lack of operational discipline, which may further undermine investor confidence and market performance.
See More
Multiple Companies Face Class Action Lawsuits
- Atara Biotherapeutics Lawsuit: Atara faces a class action from May 20, 2024, to January 9, 2026, alleging that manufacturing issues and clinical trial risks overstated its FDA approval prospects, potentially leading to significant negative impacts on its financial condition.
- Coty's Underperformance: Coty Inc. is involved in a class action from November 5, 2025, to February 4, 2026, claiming that its Consumer Beauty segment underperformed and increased marketing investments compressed margins, rendering the company's positive statements materially misleading.
- Super Micro Computer Compliance Issues: Super Micro Computer faces a class action from February 2, 2024, to March 19, 2026, due to server sales to Chinese companies violating U.S. export control laws, indicating material weaknesses in compliance controls that jeopardize business prospects.
- ImmunityBio's Overstated Capabilities: ImmunityBio is part of a class action from January 19, 2026, to March 24, 2026, alleging that executive claims about Anktiva's capabilities were materially misleading, which could undermine investor confidence in the company's operations.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit for allegedly misleading investors during the period from November 5, 2025, to February 4, 2026, following serious operational issues highlighted in its Q2 2026 earnings report and the abrupt departure of CEO Nabi, which has heightened market anxiety.
- Stock Price Impact: Following the earnings report on February 5, 2026, Coty's stock price fell over 8% that day, reflecting investor concerns about the company's future profitability, particularly after its Consumer Beauty segment reported a staggering 70% year-over-year drop in operating income.
- Market Reaction: Hagens Berman is investigating whether Coty intentionally misled investors, especially given its earlier assurances of improving sales trends for FY 2026, while the reality showed underperformance in the Consumer Beauty market and compressed margins due to increased marketing investments.
- Management Changes: The sudden departure of CEO Nabi has raised questions about the stability of Coty's management, with analysts suggesting this may be linked to the company's failure to accurately disclose its business trends, further undermining investor confidence in Coty's future prospects.
See More
